Price to Sales ratio Analysis of AcelRx Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Very Poor PS
5959.33
Period Ending - Dec-22
Very Poor PS
3.74
Growth
159191 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
5764040
PS Analysis of AcelRx Pharmaceuticals Inc
| P/S Ratio of AcelRx Pharmaceuticals Inc with value of 5764040 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of ACRX rose handsomely by 159191 % this year. |
| PS Ratio of ACRX trending up for at least three Years. |
| PS Ratio with value of 0.0352 was lowest in Year Dec-20 in last Five Years. |
| Latest PS Ratio with value of 5959.33 is Greater than Average PS of 1192.66 in last five years. |
Other PS Related Info of ACRX that may interest you.
AcelRx Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ACRX | 0.8945 | 0.86 | 4.01 % | Drug Manufacturers-Specialty & Generic |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Sales of AcelRx Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 5959.33 | 3.74 | 0.095 | 0.0352 | 0.077 | 0.061 | 0.0131 |
| Change | 159191 % | 3833.23 % | 170.20 % | -54.49 % | 27.39 % | 363.06 % | 124.62 % |
FY Chart of Price to Sales of AcelRx Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)